Pharmacists in Oak Harbor, Washington


28 Pharmacists found in Oak Harbor
male pharmacist

Mr. John F Martin, RPH


Pharmacist
31645 State Route 20, Oak Harbor, WA 98277
360-679-3522     360-679-2948

male pharmacist

Kambouzia Kiani-anaraki


Pharmacist
31645 State Route 20, Oak Harbor, WA 98277
360-679-3522    

male pharmacist

Marceli Rogoza


Pharmacist
31645 State Route 20, Oak Harbor, WA 98277
360-679-3522    



female pharmacist

Margeaux Amerine, PHARMD


Pharmacist
31490 State Route 20, Oak Harbor, WA 98277
360-675-3497     360-675-8453

female pharmacist

Marjorie Blaine, PHARMD


Pharmacist
1250 Sw Erie St, Oak Harbor, WA 98277
360-279-0671     360-279-2421

male pharmacist

Dr. Matthew Krumpak, PHARMD


Pharmacist
Naval Health Clinic Oak Harbor 3475 N Saratoga St, Oak Harbor, WA 98278
360-257-9707    

male pharmacist

Mr. Norm Skurdal, RPH


Pharmacist
32165 Sr 20, Oak Harbor, WA 98277
360-679-5546     360-679-0403

female pharmacist

Quynh Chi Huynh, PHARMD


Pharmacist
31490 Sr 20, Oak Harbor, WA 98277
360-675-3497    

male pharmacist

Ronald G. Andrade, R.PH.


Pharmacist - Pharmacotherapy
U.s. Naval Hospital, 4375 N. Saratoga Street, Oak Harbor, WA 98278
360-257-9704    

female pharmacist

Dr. Sarah Kimiko Snowden, PHARMD


Pharmacist
32170 State Road 20, Oak Harbor, WA 98277
360-675-6688     888-405-1944

female pharmacist

Vanessa Muller


Pharmacist
3475 N Saratoga St, Oak Harbor, WA 98278
360-257-9706    

male pharmacist

Dr. William Charles Eskridge, PHARMD


Pharmacist
31645 State Route 20, Oak Harbor, WA 98277
360-679-3522    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.